Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in
Advertisement

Market-Moving News for January 8th

Benzinga Newsdesk 9 months ago

MoversTrading Ideas

ACON: 54% | Aclarion Reports Triple-Digit Growth for AI Back Pain Platform as Nociscan Adoption Accelerates ACRV: 38% | Acrivon Therapeutics Announces Update On ACR-368 Program, Reports Initial Clinical

ACON: 54% | Aclarion Reports Triple-Digit Growth for AI Back Pain Platform as Nociscan Adoption Accelerates

 

ACRV: 38% | Acrivon Therapeutics Announces Update On ACR-368 Program, Reports Initial Clinical Data From ACR-2316 Phase 1 Trial, Nominates Next AP3-Enabled Preclinical Development Candidate ACR-6840

 

APLD: 8% | Applied Digital Q2 Adj. EPS $0.00 Beats $(0.10) Estimate, Sales $126.589M Beat $89.757M Estimate

Read the original

Advertisement